Literature DB >> 20806229

Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification.

Sun Och Yoon1, Cheolwon Suh, Dae Ho Lee, Hyun-Sook Chi, Chan Jeoung Park, Seong-Soo Jang, Hai-Rim Shin, Bong-Hee Park, Jooryung Huh.   

Abstract

Compared with the West, the overall incidence of lymphoid neoplasms is lower, and the subtype distribution is distinct in Asia. To comprehensively investigate the subtype distribution with the age and sex factors, and temporal changes of subtype proportions, we re-assessed all patients with lymphoid neoplasms diagnosed at a large oncology service in the Republic of Korea from 1989 to 2008 using the World Health Organization classifications. Of the total 5,318 patients, 66.9% had mature B-cell neoplasms, 12.5% had mature T/natural killer (NK)-cell neoplasms, 16.4% had precursor lymphoblastic leukemia/lymphoma (ALL/LBL), and 4.1% had Hodgkin's lymphoma. The most common subtypes were diffuse large B-cell lymphoma (30.5%), plasma cell myeloma (14.0%), extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type (MALT lymphoma; 12.4%), B-cell ALL/LBL (11.3%), Hodgkin's lymphoma (4.1%), peripheral T-cell lymphoma unspecified (4.0%), T-cell ALL/LBL (3.9%), and extranodal NK/T-cell lymphoma of nasal type (3.9%). Most subtypes showed male predominance, with an average M/F ratio of 1.3. Most mature lymphoid neoplasms were diseases of adults (mean age, 53.5 yr), whereas ALL/LBLs were of young individuals (mean age, 20.3 yr). When the relative proportion of subtypes were compared between two decades (1989-1998 vs. 1999-2008), especially MALT lymphoma has increased in proportion, whereas T/NK-cell neoplasms and ALL/LBL have slightly decreased. In summary, the lymphoid neoplasms of Koreans shared some epidemiologic features similar to those of other countries, whereas some subtypes showed distinct features. Although the increase in incidence of lymphoid neoplasms is relatively modest in Korea, recent increase of MALT lymphoma and decrease of T/NK-cell neoplasms and ALL/LBL are interesting findings.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20806229     DOI: 10.1002/ajh.21824

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  37 in total

1.  High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy.

Authors:  Yong Won Choi; Mi Sun Ahn; Jin-Hyuk Choi; Hyun Woo Lee; Seok Yun Kang; Seong Hyun Jeong; Joon Seong Park; Jae Ho Han; Jang-Hee Kim; Seung Soo Sheen
Journal:  Int J Hematol       Date:  2015-11-19       Impact factor: 2.490

Review 2.  T-cell lymphoma with von Hippel-Lindau disease: a rare case report and review of literature.

Authors:  Li-Hong Lou; Hua Shen; Jun Lin; Yi-Wen Yan; Yan Peng; Jian-Hong Lu; Qu Xu; Hai-Qiong Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Racial differences in three major NHL subtypes: descriptive epidemiology.

Authors:  Yang Li; Yu Wang; Zhuoyue Wang; Danhui Yi; Shuangge Ma
Journal:  Cancer Epidemiol       Date:  2015-01-02       Impact factor: 2.984

4.  Hematologic malignancies in elderly patients.

Authors:  Moustapha Hassan; Manuchehr Abedi-Valugerdi
Journal:  Haematologica       Date:  2014-07       Impact factor: 9.941

5.  Current status and progress of lymphoma research in East Asian countries: Introduction and planning.

Authors:  Junji Suzumiya
Journal:  Int J Hematol       Date:  2018-02-28       Impact factor: 2.490

Review 6.  Epidemiology of malignant lymphoma and recent progress in research on adult T-cell leukemia/lymphoma in Japan.

Authors:  Hiroaki Miyoshi; Koichi Ohshima
Journal:  Int J Hematol       Date:  2018-03-03       Impact factor: 2.490

7.  Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma.

Authors:  Young Ae Kim; Ja Min Byun; Keeho Park; Gi Hwan Bae; Dukhyoung Lee; Dong Sook Kim; Sung-Soo Yoon; Youngil Koh
Journal:  Blood Adv       Date:  2017-10-27

8.  Primary colorectal lymphoma-clinical outcomes in a population-based series.

Authors:  Sebastien Drolet; Anthony R Maclean; Douglas A Stewart; Elijah Dixon; Elizabeth Oddone Paolucci; W Donald Buie
Journal:  J Gastrointest Surg       Date:  2011-06-07       Impact factor: 3.452

9.  Prognostic Value of Metabolic Tumor Volume Estimated by (18) F-FDG Positron Emission Tomography/Computed Tomography in Patients with Diffuse Large B-Cell Lymphoma of Stage II or III Disease.

Authors:  Jihyun Kim; Junshik Hong; Seog Gyun Kim; Kyung Hoon Hwang; Minsu Kim; Hee Kyung Ahn; Sun Jin Sym; Jinny Park; Eun Kyung Cho; Dong Bok Shin; Jae Hoon Lee
Journal:  Nucl Med Mol Imaging       Date:  2014-05-29

Review 10.  Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.

Authors:  Lindsay C George; Martin Rowe; Christopher P Fox
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.